ZA9811505B - Novel pharmaceutical. - Google Patents

Novel pharmaceutical.

Info

Publication number
ZA9811505B
ZA9811505B ZA9811505A ZA9811505A ZA9811505B ZA 9811505 B ZA9811505 B ZA 9811505B ZA 9811505 A ZA9811505 A ZA 9811505A ZA 9811505 A ZA9811505 A ZA 9811505A ZA 9811505 B ZA9811505 B ZA 9811505B
Authority
ZA
South Africa
Prior art keywords
novel pharmaceutical
pharmaceutical
novel
Prior art date
Application number
ZA9811505A
Other languages
English (en)
Inventor
Paul David James Blackler
David C Lee
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA9811505B publication Critical patent/ZA9811505B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9811505A 1997-12-16 1998-12-15 Novel pharmaceutical. ZA9811505B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726568.0A GB9726568D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
ZA9811505B true ZA9811505B (en) 2000-11-06

Family

ID=10823694

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811505A ZA9811505B (en) 1997-12-16 1998-12-15 Novel pharmaceutical.

Country Status (37)

Country Link
US (2) US7045633B2 (fr)
EP (1) EP1045847A1 (fr)
JP (1) JP2002508372A (fr)
KR (1) KR100549143B1 (fr)
CN (3) CN101412713A (fr)
AP (1) AP1441A (fr)
AR (2) AR017213A1 (fr)
AU (1) AU2272399A (fr)
BG (1) BG64905B1 (fr)
BR (1) BR9813604A (fr)
CA (1) CA2314965A1 (fr)
CO (1) CO4990927A1 (fr)
CZ (1) CZ299970B6 (fr)
DZ (1) DZ2680A1 (fr)
EA (1) EA002355B1 (fr)
EG (2) EG21417A (fr)
GB (1) GB9726568D0 (fr)
HR (1) HRP20000405A2 (fr)
HU (1) HUP0100500A3 (fr)
ID (1) ID24744A (fr)
IL (1) IL136381A (fr)
IN (1) IN190821B (fr)
MA (1) MA26582A1 (fr)
MY (1) MY135770A (fr)
NO (1) NO317253B1 (fr)
NZ (1) NZ504704A (fr)
OA (1) OA11634A (fr)
PE (1) PE20000057A1 (fr)
PL (1) PL341147A1 (fr)
RS (1) RS50079B (fr)
SK (1) SK286197B6 (fr)
TR (2) TR200001798T2 (fr)
TW (1) TW467913B (fr)
UA (1) UA63980C2 (fr)
UY (2) UY25305A1 (fr)
WO (1) WO1999031094A1 (fr)
ZA (1) ZA9811505B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
HUP0200929A3 (en) * 1999-04-23 2004-03-29 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic and process for preparation thereof
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CO5170419A1 (es) * 1999-04-23 2002-06-27 Smithkline Beecham Plc Nuevo compuesto antidiabetico con base en sales del acido maleico
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
AU2002352391A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002352479A1 (en) * 2001-12-20 2003-07-09 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (fr) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Procédé de préparation de formes galéniques solides de maléate de rosiglitazone

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (fr) 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
AU5082993A (en) 1992-08-28 1994-03-29 Merck & Co., Inc. Cationic-2-heteroarylphenyl-carbapenem antibacterial agents
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW245716B (fr) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) * 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
CZ432299A3 (cs) * 1998-06-02 2000-08-16 Smithkline Beecham Plc Kompozice obsahující 5-[4-[2-(N-methyl-N-(2- pyridyI)amino)ethoxy]benzyl]thiazolidin-2,4-dion
PE20010044A1 (es) 1999-04-23 2001-03-10 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
CO5170419A1 (es) 1999-04-23 2002-06-27 Smithkline Beecham Plc Nuevo compuesto antidiabetico con base en sales del acido maleico
HUP0200929A3 (en) 1999-04-23 2004-03-29 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic and process for preparation thereof

Also Published As

Publication number Publication date
JP2002508372A (ja) 2002-03-19
CZ299970B6 (cs) 2009-01-07
IN190821B (fr) 2003-08-23
EG23694A (en) 2007-05-15
NZ504704A (en) 2003-03-28
AR017213A1 (es) 2001-08-22
CN101412713A (zh) 2009-04-22
ID24744A (id) 2000-08-03
RS50079B (sr) 2009-01-22
EP1045847A1 (fr) 2000-10-25
CN101412714A (zh) 2009-04-22
TR200001798T2 (tr) 2000-11-21
NO20003068L (no) 2000-06-15
BG64905B1 (bg) 2006-08-31
AP2000001830A0 (en) 2000-06-30
TR199802626A2 (xx) 1999-10-21
PE20000057A1 (es) 2000-03-09
UA63980C2 (en) 2004-02-16
TR199802626A3 (tr) 1999-10-21
BR9813604A (pt) 2000-10-10
GB9726568D0 (en) 1998-02-11
SK9102000A3 (en) 2001-01-18
BG104595A (en) 2001-02-28
TW467913B (en) 2001-12-11
MY135770A (en) 2008-06-30
EA200000655A1 (ru) 2000-12-25
UY25310A1 (es) 1999-07-19
CA2314965A1 (fr) 1999-06-24
US7045633B2 (en) 2006-05-16
NO317253B1 (no) 2004-09-27
OA11634A (en) 2004-11-22
CZ20002205A3 (cs) 2000-11-15
IL136381A (en) 2003-09-17
US20060189659A1 (en) 2006-08-24
AR017430A1 (es) 2001-09-05
UY25305A1 (es) 2000-12-29
WO1999031094A1 (fr) 1999-06-24
YU36200A (sh) 2003-12-31
AU2272399A (en) 1999-07-05
CN1281454A (zh) 2001-01-24
IL136381A0 (en) 2001-06-14
PL341147A1 (en) 2001-03-26
DZ2680A1 (fr) 2005-02-20
KR20010033142A (ko) 2001-04-25
MA26582A1 (fr) 2004-12-20
EA002355B1 (ru) 2002-04-25
AP1441A (en) 2005-07-30
NO20003068D0 (no) 2000-06-15
HRP20000405A2 (en) 2000-12-31
US20040097553A1 (en) 2004-05-20
HUP0100500A3 (en) 2002-08-28
KR100549143B1 (ko) 2006-02-03
HUP0100500A2 (hu) 2002-05-29
CO4990927A1 (es) 2000-12-26
EG21417A (en) 2001-10-31
SK286197B6 (sk) 2008-05-06

Similar Documents

Publication Publication Date Title
ZA989061B (en) Medicaments.
HK1027957A1 (en) Pharmaceutical composition.
ZA972685B (en) Medicaments.
ZA965190B (en) Pharmaceutical composition.
ZA9811849B (en) Vaccine.
HK1025746A1 (en) Syringe.
ZA9710071B (en) Pharmaceutical composition.
ZA981029B (en) Pharmaceutical agents.
ZA9710927B (en) Pharmaceutical composition.
HK1016976A1 (en) Resorcinyl-triazine.
ZA9811504B (en) Novel pharmaceutical.
ZA9811506B (en) Novel pharmaceutical.
ZA989680B (en) Pharmaceutical composition.
ZA9811505B (en) Novel pharmaceutical.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA968081B (en) Pharmaceutical composition.
HK1022853A1 (en) Pharmaceutical compositions.
ZA987392B (en) Pharmaceutical composition.
ZA982436B (en) Thiazolimine derivatives.
HK1017834A1 (en) Bodyshaper.
ZA983705B (en) Pregnan-3-ol-20-ones.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA97310B (en) Pharmaceuticals.
ZA982558B (en) Novel Pharmaceutical.